Public Sector Pension Investment Board grew its position in shares of Cencora, Inc. (NYSE:COR - Free Report) by 53.2% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 6,908 shares of the company's stock after buying an additional 2,400 shares during the quarter. Public Sector Pension Investment Board's holdings in Cencora were worth $1,555,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors and hedge funds also recently made changes to their positions in COR. New Millennium Group LLC bought a new position in Cencora during the 2nd quarter valued at about $26,000. MFA Wealth Advisors LLC purchased a new position in shares of Cencora in the second quarter worth approximately $30,000. Concord Wealth Partners purchased a new position in shares of Cencora during the 3rd quarter worth $30,000. SYSTM Wealth Solutions LLC bought a new stake in Cencora during the second quarter valued at about $36,000. Finally, Ashton Thomas Securities LLC purchased a new stake in Cencora in the 3rd quarter worth approximately $41,000. Institutional investors own 97.52% of the company's stock.
Analysts Set New Price Targets
A number of research firms have commented on COR. StockNews.com cut Cencora from a "strong-buy" rating to a "buy" rating in a report on Friday, September 20th. Bank of America reiterated a "neutral" rating and issued a $245.00 price target (down from $275.00) on shares of Cencora in a report on Wednesday, September 18th. Leerink Partners cut their price objective on Cencora from $277.00 to $275.00 and set an "outperform" rating for the company in a research report on Monday, October 7th. Evercore ISI boosted their target price on Cencora from $250.00 to $285.00 and gave the stock an "outperform" rating in a research report on Thursday, November 7th. Finally, UBS Group raised their price target on Cencora from $275.00 to $285.00 and gave the company a "buy" rating in a report on Thursday, November 7th. Two analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $276.80.
Get Our Latest Analysis on COR
Insider Activity
In other Cencora news, Chairman Steven H. Collis sold 21,509 shares of the firm's stock in a transaction dated Tuesday, November 19th. The stock was sold at an average price of $242.16, for a total value of $5,208,619.44. Following the completion of the sale, the chairman now owns 306,752 shares of the company's stock, valued at approximately $74,283,064.32. This trade represents a 6.55 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In the last ninety days, insiders have sold 93,018 shares of company stock worth $22,478,942. Corporate insiders own 15.80% of the company's stock.
Cencora Stock Down 0.4 %
Shares of COR traded down $0.90 during trading hours on Friday, hitting $243.41. The company had a trading volume of 1,199,812 shares, compared to its average volume of 1,126,541. Cencora, Inc. has a one year low of $195.83 and a one year high of $253.27. The company's fifty day moving average price is $237.12 and its two-hundred day moving average price is $233.46. The company has a market capitalization of $47.05 billion, a PE ratio of 32.41, a price-to-earnings-growth ratio of 1.65 and a beta of 0.45. The company has a current ratio of 0.88, a quick ratio of 0.53 and a debt-to-equity ratio of 4.84.
Cencora Increases Dividend
The company also recently declared a quarterly dividend, which was paid on Friday, November 29th. Shareholders of record on Friday, November 15th were given a dividend of $0.55 per share. This represents a $2.20 annualized dividend and a dividend yield of 0.90%. This is a positive change from Cencora's previous quarterly dividend of $0.51. The ex-dividend date of this dividend was Friday, November 15th. Cencora's dividend payout ratio is presently 29.29%.
About Cencora
(
Free Report)
Cencora, Inc sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers.
Featured Articles
Before you consider Cencora, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cencora wasn't on the list.
While Cencora currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.